Myocardial fibrosis and MitraClip: Does it even matter? | Zendy

Shatila Wassim | Zendy; Krajcer Zvonimir | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Myocardial fibrosis and MitraClip: Does it even matter?

Author(s) -

Shatila Wassim,

Krajcer Zvonimir

Publication year - 2019

Publication title -

catheterization and cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.988

H-Index - 116

eISSN - 1522-726X

pISSN - 1522-1946

DOI - 10.1002/ccd.28311

Subject(s) - mitraclip , medicine , cardiology , atrial fibrillation , mitral regurgitation , fibrosis , myocardial fibrosis , magnetic resonance imaging , radiology

Key Points Preprocedural myocardial fibrosis as identified by magnetic resonance imaging correlates with worse outcomes after MitraClip placement. Post‐MitraClip mitral regurgitation gradient >2 or ischemic cardiomyopathy also correlates with worse outcomes. In the literature, other variables are mentioned (e.g., severe tricuspid regurgitation, atrial fibrillation, postoperative mitral valve area and/or gradient) that correlate with worse post‐MitraClip outcomes.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research